HDAC inhibition upregulates the expression of angiostatic ADAMTS1
Abstract
HDAC inhibitors are promising anticancer agents that induce cell cycle arrest and apoptosis. However, the role of HDACs in cancer progression, such as angiogenesis and metastasis, remains largely unexplored. Among various HDAC inhibitors, we demonstrate that TSA and SAHA upregulated the expression of angiostatic ADAMTS1 in A549 cells. HDAC6 inhibitor tubacin, and knockdown of HDAC6, also lead to ADAMTS1 upregulation. By reporter, DAPA, and ChIP assays, the proximal GC boxes were demonstrated to be essential for ADAMTS1 induction. Decreased binding of SP1 and HDAC6 to the ADAMTS1 promoter after TSA treatment was also seen. These data suggest the involvement of HDAC6 and SP1 in the HDACi-induced expression of angiostatic ADAMTS1.
Abbreviations: HDAC, histone deacetylase, ADAMTS, a disintegrin and metalloproteinase with thrombospondin motif
Keywords: ADAMTS1, SP1, HDAC6, TSA, SAHA
To access this article, please choose from the options below
PII: S0014-5793(08)00895-8
doi:10.1016/j.febslet.2008.10.048
© 2008 Federation of European Biochemical Societies. Published by Elsevier BV. All rights reserved.
Refers to corrigendum:
- Corrigendum to “HDAC inhibition upregulates the expression of angiostatic ADAMTS1” [FEBS Lett. 582 (2008) 4059–4065] , 13 January 2009
